Antithrombin iii human

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

5153 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Breast neoplasms	D001943	EFO_0003869	C50	27	50	152	1	93	305
Atrial fibrillation	D001281	EFO_0000275	I48.0	3	36	43	74	148	301
Neoplasms	D009369	—	C80	46	46	92	7	76	246
Thrombosis	D013927	—	—	22	36	75	47	65	235
Thromboembolism	D013923	HP_0001907	—	15	46	74	34	55	216
Venous thromboembolism	D054556	EFO_0004286	I74	11	38	59	23	51	176
Lymphoma	D008223	—	C85.9	28	53	65	1	16	150
Syndrome	D013577	—	—	16	29	43	17	39	137
Venous thrombosis	D020246	HP_0004936	I82.40	9	20	55	18	37	132
Leukemia	D007938	—	C95	17	28	60	1	12	113

Show 224 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Lung neoplasms	D008175	HP_0100526	C34.90	26	73	93	—	48	218
Non-small-cell lung carcinoma	D002289	—	—	25	78	98	—	35	215
Carcinoma	D002277	—	C80.0	22	54	112	—	27	192
Healthy volunteers/patients	—	—	—	125	5	4	—	14	148
Melanoma	D008545	—	—	40	58	17	—	20	123
Colorectal neoplasms	D015179	—	—	14	24	56	—	40	121
Prostatic neoplasms	D011471	—	C61	10	14	60	—	27	109
Ovarian neoplasms	D010051	EFO_0003893	C56	22	30	33	—	22	100
Adenocarcinoma	D000230	—	—	17	27	43	—	9	87
Ovarian epithelial carcinoma	D000077216	—	—	14	19	24	—	21	75

Show 733 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Heart arrest	D006323	EFO_0009492	I46	—	1	—	—	6	7
Spinal muscular atrophy	D009134	EFO_0003823	G12.1	1	1	—	—	5	6
Malocclusion	D008310	HP_0000689	M26.4	—	1	—	—	5	6
Adenoma	D000236	—	—	—	1	—	—	4	5
Joint diseases	D007592	HP_0003040	M12.9	1	2	—	—	3	5
Laryngeal diseases	D007818	—	J38.7	1	3	—	—	2	5
Meningioma	D008579	EFO_0003098	D32.9	—	4	—	—	1	5
Anxiety	D001007	EFO_0005230	F41.1	1	1	—	—	4	5
Lobular carcinoma	D018275	EFO_0000570	—	2	2	—	—	1	5
Dentin sensitivity	D003807	—	—	—	1	—	—	4	5

Show 85 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Metabolic syndrome	D024821	EFO_0000195	E88.810	1	—	—	—	8	9
Coagulation protein disorders	D020147	—	—	3	—	—	—	4	7
Inflammatory bowel diseases	D015212	EFO_0003767	—	1	—	—	—	4	5
Drug interactions	D004347	—	—	5	—	—	—	—	5
Therapeutic equivalency	D013810	—	—	5	—	—	—	—	5
Metabolic diseases	D008659	EFO_0000589	E88.9	1	—	—	—	4	5
Hepatic insufficiency	D048550	—	—	3	—	—	—	1	4
Crush injuries	D000071576	—	T14.8	1	—	—	—	2	3
Cigarette smoking	D000073865	—	—	1	—	—	—	2	3
Suicide	D013405	—	—	1	—	—	—	2	3

Show 26 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Cerebral palsy	D002547	—	G80	—	—	—	—	14	14
Exercise	D015444	EFO_0000483	—	—	—	—	—	9	9
Neck pain	D019547	HP_0030833	M54.2	—	—	—	—	8	8
Paralysis	D010243	HP_0003470	—	—	—	—	—	7	7
Pressure ulcer	D003668	—	—	—	—	—	—	7	7
Sedentary behavior	D057185	—	—	—	—	—	—	6	6
Insulin resistance	D007333	HP_0000855	—	—	—	—	—	5	5
Prolapse	D011391	—	—	—	—	—	—	5	5
Bursitis	D002062	EFO_1000941	M71.9	—	—	—	—	5	5
Child development	D002657	—	—	—	—	—	—	5	5